Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 1046-1052

  Yen, Tzung Hai ^a,c   Huang, Chiu Ching ^b   Lin, Hsin Hung ^b   Huang, Jeng Yi ^a   Tian, Ya Chun ^a   Yang, Chih Wei ^a   Wu, Mai Szu ^a   Fang, Ji Tseng ^a   Yu, Chun Chen ^a   Chiang, Yang Jen ^a   Chu, Sheng Hsieh ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Co infection; HBV; HCV; Reactivation; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GENE EXPRESSION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUPERINFECTION; VIRUS CARRIER; VIRUS GENE; VIRUS REACTIVATION;

ADULT; FEMALE; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; LAMIVUDINE; MALE; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS ACTIVATION;

EID: 33645293435     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk023     Document Type: Article

References (20)

1. Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997; 12: S236-S241
2. Huang CC, Liaw YF, Lai MK, Chu SH, Chuang CK, Huang JY. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992; 53: 763-765
3. Lin HH, Huang CC, Huang JY et al. Impact of HCV infection on first cadaveric renal transplantation, a single center experience. Clin Transplant 2004; 18: 261-266
4. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004; 126: 1024-1029
5. Zylberberg H, Carnot F, Mamzer MF, Blancho G, Legendre C, Pol S. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63: 158-160
6. Milich DR. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 1988; 9: 380-386.
7. Chisari FV, Filippi P, Buras J et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987; 84: 6909-6913
8. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986; 83: 1627-1631
9. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994; 107: 189-195
10. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14: 64-67
11. Fattovich G, Tagger A, Brollo L et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991; 163: 400-402
12. Pontisso P, Ruvoletto MG, Fattovich G et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-1533
13. Sato S, Fujiyama S, Tanaka M et al. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159-166
14. Liaw YF, Tsai SL, Chang JJ et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 1048-1053
15. Pontisso P, Gerotto M, Ruvoletto MG et al. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996; 48: 157-160
16. Chu CM, Yeh CT, Liaw YF. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 1998; 36: 2084-2086
17. Pouteil-Noble C, Tardy JC, Chossegros P et al. Co-infection by hepatitis B virus and hepatitis C virus in renal transplantation: Morbidity and mortality in 1098 patients. Nephrol Dial Transplant 1995; 10 [Suppl 6]: 122-124
18. Breitenfeldt MK, Rasenack J, Berthold H et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002; 16: 130-136
19. Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-263
20. Fornairon S, Pol S, Legendre C et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 62: 297-299